HCM
EXAS

Highbridge Capital Management’s Exact Sciences EXAS Stock Holding History

Highbridge Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-52,900
Closed -$648K – 1405
2016
Q2 		$648K Sell
52,900
-85,000
-62% -$640K 0.01% 755
2016
Q1 		$930K Buy
+137,900
New +$882K 0.02% 764

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Highbridge Capital Management's EXAS Position: Q1 2026 in Review

Highbridge Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 480,733 shares — an estimated $48.8M sold.

Highbridge Capital Management first reported a position in EXAS in Q3 2016 and held it in 3 quarters. The position peaked at $48.8M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Highbridge Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Highbridge Capital Management sold 480,733 Exact Sciences shares in Q1 2026, an estimated $48.8M.
  • Highbridge Capital Management first reported a position in Exact Sciences in Q3 2016 and held it in 3 quarters.
  • Highbridge Capital Management's Exact Sciences position peaked at $48.8M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Highbridge Capital Management's 13F filing for Q1 2026, filed 15 May 2026.